The neuropathological landscape of Hispanic and non-Hispanic White decedents with Alzheimer disease.

"availability of data and materials if accepted for publication and after journal release of the formal formatted manuscript associated data will be available through dryad ( https://datadryad org/stash ). availability of data and materials if accepted for publication and after journal release of the formal formatted manuscript associated data will be available through dryad"

"Declarations Competing interestsThis project was primarily made possible by grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Numbers R01AG062517, P30AG072972, P30AG062429, P50AG008702, P30AG066462. BND: receives funding by grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Numbers P30AG072972, U01AG061357-S1, R01AG052132, R01AG056519, and R01AG062517. She serves on the external advisory board for the Alzheimer’s Disease Center at USC, and as a committee member for the ADRC neuropathology committee and the College of American Pathologists Neuropathology committee. She has no conflicts of interest to declare related to this project. LB: has received support over the last 48 months from payments to her institution from U01AG024904 (Dr. Weiner, UCSF/NCIRE), R01AG062517 (Dr. Dugger), B639943 (Dr. Coleman), and the National Institute of Justice 2014-R2-CX-0012 (Dr. Wintemute). She has served on the external advisory boards for Alzheimer’s Disease Centers at UCSD, Washington University, University of Pittsburgh, and Data and Safety Monitoring Boards for NIH-funded clinical trials (UCSF), and as an external advisory board member for the LEADS study, all paid directly to her. She has no other support or conflicts of interest to declare. RR has received support from AG058252, AG073979, AG051848 to RAR and biomarker. Other authors report no conflicts of interest relevant to this project. Competing interests This project was primarily made possible by grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Numbers R01AG062517, P30AG072972, P30AG062429, P50AG008702, P30AG066462. BND: receives funding by grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Numbers P30AG072972, U01AG061357-S1, R01AG052132, R01AG056519, and R01AG062517. She serves on the external advisory board for the Alzheimer’s Disease Center at USC, and as a committee member for the ADRC neuropathology committee and the College of American Pathologists Neuropathology committee. She has no conflicts of interest to declare related to this project. LB: has received support over the last 48 months from payments to her institution from U01AG024904 (Dr. Weiner, UCSF/NCIRE), R01AG062517 (Dr. Dugger), B639943 (Dr. Coleman), and the National Institute of Justice 2014-R2-CX-0012 (Dr. Wintemute). She has served on the external advisory boards for Alzheimer’s Disease Centers at UCSD, Washington University, University of Pittsburgh, and Data and Safety Monitoring Boards for NIH-funded clinical trials (UCSF), and as an external advisory board member for the LEADS study, all paid directly to her. She has no other support or conflicts of interest to declare. RR has received support from AG058252, AG073979, AG051848 to RAR and biomarker. Other authors report no conflicts of interest relevant to this project."

"Funding This project was primarily made possible by grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under Award Numbers R01AG062517, P30AG072972, P30AG062429, P50AG008702, P30AG066462."